Dec 30, 2014
Russian pharmaceutical company Generium has signed an agreement with Canada's ProMetic Life Sciences to develop several plasma-derived biopharmaceuticals as well.
seen from United States
seen from United States
seen from United States
seen from United States
seen from Australia
seen from United States
seen from United States
seen from United Kingdom
seen from Malaysia
seen from Netherlands
seen from United States
seen from China
seen from United States
seen from Malaysia
seen from Netherlands
seen from United States
seen from China
seen from India
seen from United States
seen from United States
Russian pharmaceutical company Generium has signed an agreement with Canada's ProMetic Life Sciences to develop several plasma-derived biopharmaceuticals as well.